Gene Codes

Gene Codes has released Sequencher 5.2, the latest version of its DNA sequence data analysis software.

The company is appealing a US District Court's ruling in a suit it filed against the Office of the Chief Medical Examiner of New York, which granted the city's motion for summary judgment.

The judge denied Gene Codes' request for discovery in a suit it filed against the Office of the Chief Medical Officer of New York and granted the city's motion for summary judgment in the case.

Downloads and Upgrades

Premium

Avadis NGS, Genome Trax, Ask Extractor, Journal Trends, GenePattern 3.3.2, Sequencher 5.0, ExPASy

New Products

Premium

Roche's 454 GS FLX+ system, Gene Codes' Sequencher

Gene Codes claims that New York City's Office of the Medical Examiner violated its contract with the company by providing the FBI with access to trade secrets and confidential information about its DNA-matching software, M-FISys. The city maintains its innocence and has called for the case to be dismissed.

In its suit, Gene Codes alleges New York's Office of Chief Medical Examiner infringed on its software developed to identify victims of the 9/11 attack at Ground Zero from DNA. The city is countersuing.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.